FDA authorizes first breathalyzer test to detect COVID-19 

The Food and Drug Administration yesterday authorized for emergency use the first COVID-19 breathalyzer test for adults, which can detect the virus in breath samples in under three minutes under the supervision of a health care provider licensed or authorized to prescribe tests. Positive results should be treated as presumptive and confirmed with a molecular test. For more information, see the fact sheet for health care providers.